Tender Details
Ref No 20160091
Document

Tender Notice

Bidding

Not specified

Short Description

Serv. Elab.D.Teh.-Ec., Pt+Pac Phase+Coexistence Study+Pad+Poe Dde+Assist. Techn. From The Designer Along The Way. The Execution Of The Exec. Work+Verif. Doc. Design By The Certificate Projects Verify+ Doc. Opinions (If Applicable) And Work Execution. Within The Project: Urban Regeneration By Revitalizing The Central Area - Piata M/ Viteazul Craiova R.E.G.E.N.E.R.A.T.E Craiova - Zona M.Viteazul ”
Funding Agency
Funding Agency European Union
Deadline *
Date 15 Sep 2025
* The estimated cost, values & dates are indicative only. Please read tender document for accurate information.
Client Address
Location Romania
More Information
Know More

FREE Trial Plan For All New Users!

Start your Business.

Similar Tenders

  • Ref No: 5226698
  • Location: Germany

Medicines With The Active Ingredient Combination Formoterol Glycopyrronium Bromide And Beclometasone Atc R03Al09

  • Deadline: 31 Mar 2026
  • Ref No: 5976401
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Baclofen In The Dosage Form Inf

  • Deadline: 10 May 2026
  • Ref No: 5968352
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine In The Dosage

  • Deadline: 10 May 2026
  • Ref No: 5977462
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Brimonidine In The Dosage Form

  • Deadline: 10 May 2026
  • Ref No: 5978310
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ebastine In The Strength 20 Mg

  • Deadline: 10 May 2026
  • Ref No: 5978859
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Epinephrine In The Dosage Form

  • Deadline: 10 May 2026
  • Ref No: 7418394
  • Location: United States

Detroit Supply Schedule 5 Printing Services

  • Deadline: 30 Jun 2028
  • Ref No: 7461971
  • Location: United States

Detroit Supply Schedule 5 Printing Services

  • Deadline: 30 Jun 2028
  • Ref No: 7484008
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Codeine In The Dosage Form Tei

  • Deadline: 10 May 2026
  • Ref No: 7483851
  • Location: United States

Detroit Supply Schedule 5 Printing Services

  • Deadline: 30 Jun 2028
  • Ref No: 7485133
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Testosterone Enanthate Undeca

  • Deadline: 10 May 2026
  • Ref No: 7512094
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Chlorthalidone In The Dosage Fo

  • Deadline: 10 May 2026
  • Ref No: 7900828
  • Location: United States

Detroit Supply Schedule 5 Printing Services

  • Deadline: 30 Jun 2028
  • Ref No: 7584847
  • Location: United States

Detroit Supply Schedule 5 Printing Services

  • Deadline: 30 Jun 2028
  • Ref No: 7647673
  • Location: United States

Detroit Supply Schedule 5 Printing Services

  • Deadline: 30 Jun 2028
WhatsApp Chat